January 2016
TABLE OF CONTENTSCluster's lifeOur member's newsSave the dateCalls for projectsAround our themes

A great beginning in 2016, with news accompanying tools for Lyonbiopole members !

 

In January  we have settled different workshops on themes like : the legislation in Health Sector, the research tax credit or the fundraising. This first month of the year was also marked by the visit of M. François Fillon in BIOASTER and the discover of our health ecosystem, the presentation at Clermont-Ferrand of Lyonbiopole to the Innovative Companies of Auvergne and also the launch of the european project bioXclusters.

 

Finally, we invite you to discover, February 22nd, the training " IDPS - Immersion in Development of Healthcare Industry ", created in partnership with The Foundation for the University of Lyon and Claude Bernard 1 University.

Cluster's life

 The European Commission renews its support to the bioXclusters allianceLaunched in 2012, the alliance that gathers Lyonbiopole and its 3 partners Biocat, BioM and BioPmed aims to reinforce synergies between the 4 clusters mutualizing their forces and competences to support SME internationalization. For the next 24 months, thanks to the EC support, the alliance will structure strategic partnerships with 4 target markets (Brazil, China, US and Japan) and put in place tools and actions for SMEs.
 Visit of M. François Fillon in BIOASTERFrançois Fillon visited at the end of the month BIOASTER in the presence of Alain Mérieux. This visit allowed to expose the richness and density of the health local ecosystem. Emphasis was also placed on the innovative capacity of the Auvergne Rhône-Alpes region.
 Lyonbiopole introduces itself to the Auvergne companiesFollowing the regions merger realised in France in January 1st 2016, the Rhône-Alpes region merged with the Auvergne region to form the Auvergne Rhône-Alpes region. To initiate the work with the actors of this new integrated territory, Lyonbiopole presented its activities and actions to meet the needs of businesses. Moreover, a review of the Rhonalpin pharmaceutical ecosystem and potential collaborative tracks with the Auvergn economic make-up were presented.

Our member's news

 New member Nemera is a world leader in the design, development and manufacturing of drug delivery solutions, providing solutions for the pharmaceutical, biotechnology & generics industries, including standard innovative products and development of custom devices and contract manufacturing. […]
 New memberInovotion offers a new generation of in vivo efficacy and toxicity tests, fast, sensitive, reliable and affordable, based on human cancer cell lines in chick egg embryo. They are intended for chemists and biologists […]
 Focus onInnate Pharma and OREGA Biotech announced that they have entered into an exclusive licensing agreement by which OREGA Biotech grants Innate Pharma full worldwide rights to its program of first-in-class anti-CD39 checkpoint inhibitors. This license agreement arose from a fruitful research collaboration between the two companies initiated in 2014.
 January 5th, 2016Erytech announces management change January 5th, 2016bioMérieux acquires Applied Maths January 6th, 20161st patient randomized with Transgene Pexa-Vec
 January 7th, 2016Erytech announces continuation of its phase 2B study January 12th, 2016Early immune effect of SCIB1 cancer vaccine observed  January 13th, 2016Novasep and Advanced Biotherapeutics Consulting team up
 January 20th, 2016Early Immune Effect of SCIB1 Cancer Vaccine Observed in Blood by ImmunTraCkeR® Companion Diagnostic January 20th, 2016Collaboration between Px'therapeutics and Intervacc January 21th, 2016ADNucleis develops a polymerase chain reaction – PCR
 January 28th, 2016Novasep adds synthesis and kilo lab extensions to US facility January 29th, 2016Adocia and Lilly initiate Phase 1b February 3th, 2016Erytech to present at upcoming investor conferences
 February 4th, 2016Neolys Diagnostic on WiSEED

Save the date

 
  • BIOVISION 2016
    April 13th, 2016

  • See All events

    Calls for projects

     

    EUROPE & INTERNATIONAL

  • Eurostars 2
    Before February 18th, 2016
  • Innovative Medicines Initiative – IMI 2
    Before March 17th, 2016
  • H2020 Health Personalised Medicine calls for projects
    Before April 13th, 2016
  • H2020 SME instrument
    Before October 15th, 2016
  • Around our themes

     
  • Accinov – Nanolive
    February 4th, 2016
  • Accinov – Pall Life Sciences
    February 11th, 2016
  • INSERM workshop « Advanced approaches for fighting bacterial antibiotic resistance »
    March 1st, 2016
  • Upcoming AMP2016 international symposium on antimicrobial peptides
    June 6th, 2016
  • Bâtiment Domilyon

    321, avenue Jean Jaurès

    69007 Lyon

    Tel. : +33 (0)4 72 76 53 30

    Fax : +33 (0)9 55 91 30 26

    www.lyonbiopole.com

    info@lyonbiopole.com

    TwitterLinkedInrss

     

    This email has been sent automatically to [[EMAIL_TO]]. Click here to unsubscribe.